1.
Efficacy and Safety of Dapagliflozin as Adjunct Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea. ajm [Internet]. 2026 Oct. 23 [cited 2026 Oct. 25];9(2):201-5. Available from: https://medjournal.co.in/index.php/ajm/article/view/358